SATURN研究解读.ppt

  1. 1、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。。
  2. 2、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  3. 3、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
查看更多
Percentage Atheroma Volume PAV is calculated by expressing the atheroma volume B-A as a percentage of the volume of the vessel contained within the EEM B throughout the region of interest. So as a formula this becomes: PAV ∑ B – A x 100 ∑ B ? * * The primary endpoint of the study is change in PAV in a target segment of coronary artery assessed which must be at least 40mm in length . Change in PAV will be calculated by subtracting the PAV prior to treatment from the PAV at the end of the study. For regression this number will be a negative value. Abbreviations PAV percent atheroma volume; IVUS intravascular ultrasound * The secondary IVUS endpoint is change in ‘normalised’ TAV of the targeted coronary artery. Normalised TAV will be calculated as the average atheroma area multiplied by the median number of comparable cross sections in all patients in the analysis. Normalising in this way adjusts for pullbacks of differing lengths thereby resulting in an equal weighting of each individual patient. Abbreviations IVUS intravascular ultrasound; TAV total atheroma volume * Baseline demographics for the population of patients completing the trial with an evaluable final IVUS procedure. * Baseline demographics for the population of patients completing the trial with an evaluable final IVUS procedure. * Baseline demographics for the population of patients completing the trial with an evaluable final IVUS procedure. * Baseline demographics for the population of patients completing the trial with an evaluable final IVUS procedure. * * * * * * * * Results for the population of patients completing the trial with an evaluable final IVUS procedure. * Results for the population of patients completing the trial with an evaluable final IVUS procedure. 1.8是上限,并非下限 * * * * * * Whilst it is acknowledged that there are limitations in comparing data and results from different studies, this slide summarises the data from several IVUS studies and pro

文档评论(0)

baobei + 关注
实名认证
内容提供者

该用户很懒,什么也没介绍

1亿VIP精品文档

相关文档